You don't need much money to get started investing. And stocks with relatively low share prices have tremendous growth prospects.

Three Fool.com contributors identified no-brainer healthcare stocks to buy for under $100. Here's why they chose CRISPR Therapeutics (NASDAQ: CRSP), Novocure (NASDAQ: NVCR), and (NYSE: PFE). 

David Jagielski (CRISPR Therapeutics):  Shares of CRISPR Therapeutics are trading below $70, but it may not be long before they take off. The company has a promising gene-editing therapy in exa-cel for rare blood disorders beta-thalassemia and sickle cell disease that it has been working on with Vertex Pharmaceuticals. Even at $1.9 million per dose, it could be a cost-effective therapy, given that it can be a functional cure for diseases that up until now have required continuous, ongoing treatment.

Continue reading

Source Fool.com